EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Does Expanded Tukysa Approval Change The Bull Case For Pfizer (PFE)?
Pfizer or Kraft Heinz: Only One Gets My Dividend Dollars for the Next 10 Years
RBC Capital Reaffirms Their Hold Rating on Pfizer (PFE)
Health Care Down, But not by Much, Amid Defensive Bias - Health Care Roundup | Morningstar
Pfizer (NYSE:PFE) Shares Up 3% - Here's What Happened - Zolmax
Bristol Myers Squibb's 4.2% Dividend Yield Comes With a Trade-Off Investors Should Know
Pfizer vs. AbbVie: Is the Cheaper Pharma Stock Really the Better Investment?
Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady
Moderna Tumbles 10% as Profit Taking Hits Cancer Vaccine Rally; BioNTech Eases, Pfizer Stays Put
Tukysa Approval Might Change The Case For Investing In Pfizer Stock (PFE)
Training the next generation of hepatologists for the cardiovascular-kidney-metabolic era
Ankylosing Spondylitis Market in the US to Grow from USD 3,366.93 Million at a CAGR of 8.36% Through 2032 | ABNewswire
Pharmaceutical Stocks To Keep An Eye On - October 15th - Zolmax
Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher
Big pharma is pouring billions into a new class of 'protein degrader' drugs | World News
Pfizer (NYSE:PFE) vs. Iterum Therapeutics (NASDAQ:ITRM) Head-To-Head Contrast - Markets Daily
Pfizer Inc. (PFE) - What Are Researchers Thinking About This Stock?
Combination therapy for BCG-unresponsive non-muscle-invasive bladder cancer: biological rationale and ongoing clinical strategies
Pfizer (NYSE:PFE) Stock Price Up 3% - Still a Buy?
Pfizer (NYSE:PFE) Hits New 12-Month High - What's Next?
Pfizer (NYSE:PFE) Stock Sees Unusually High Call Option Buying - Daily Political
Enodia and Pfizer collaborate on Sec61 inhibitors
5 Large-Cap Giants Paying 5% and Bigger Dividends to Be Bought and Held Forever
Pfizer (NYSE:PFE) Hits New 12-Month High - Still a Buy? - Daily Political
Pfizer (PFE) Signs Sec61 Drug Discovery Deal With A Research Partner
Pfizer partners with Enodia Therapeutics in $500m drug deal
Talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer: a randomized phase 2 trial
Pfizer or Enbridge: Only One Gets My Dividend Dollars for the Next 10 Years
What Is Pfizer (PFE) Really Gaining From Its Sec61 Drug Discovery Deal?
Pfizer (PFE) Pays Out Over 226% of Earnings and Trades at 36.7x Trailing Against 9.8 Forward. What Is the Yield Telling You?
Johnson & Johnson Drops 5% as One-Time Charges Overshadow Raised Full-Year Outlook; Eli Lilly Dips, Pfizer Sits Out the Selloff
These 6 Dividend Stocks Look Like Income Bargains. Their Payout Ratios Say Otherwise
Pfizer FY2026 Earnings Forecast Raised by Erste Group Bank
Analysts Offer Insights on Healthcare Companies: Cogstate Ltd (OtherCOGZF) and Pfizer (PFE)
Type 2 Diabetes Market Set for Robust Growth Driven by Innovation and Pipeline Advances by 2036 - DelveInsight | Eli Lilly, Regor Pharma, AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences, MediciNova | ABNewswire
New Evidence Raises Questions About Whether Military's COVID Vaccine Mandate Was Legal - Activist Post
How to Play PFE Stock as Pfizer Cuts 300 Jobs
Every Roth IRA Needs These High-Yield Dividend Stocks Over 6%
4 Blue Chip Giants That May Have to Cut Their Dividends
NSCLC Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | AbbVie, Xcovery, Sanofi, Pfizer, Mirati Therapeutics, AstraZeneca, Daiichi Sankyo, Merck | ABNewswire
Pfizer Is Trading at Less Than 10 Times Earnings. But Is the Stock Actually Cheap?
These 4 Dividend Stocks Offer Tempting Yields. But the Warning Signs Are Getting Harder to Ignore
Pfizer (NYSE:PFE) Downgraded by Wall Street Zen to "Hold"
Pfizer And 2 Other Top AI Healthcare Stocks
CDs vs. Dividend Stocks: The Income Gap Could Be Bigger Than Retirees Think
$12,300 a Month in Dividends and Not One Bond: Is This Portfolio Too Good to Be True?
Pfizer Inc. $PFE Stock Acquired by Wedmont Private Capital
Pfizer (NYSE:PFE) Stock Gets Downgrade from Wall Street Zen
Pfizer (NYSE:PFE) Shares Climb 1.6% on Analyst Upgrade - Markets Daily
Pfizer (NYSE:PFE) Stock Jumps 1.6% Following Analyst Upgrade
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Pfizer (NYSE:PFE) Stock
Pfizer's Dividend Yield Is Above 6%. Wall Street May Be Sending a Warning - 24/7 Wall St.
Moderna stock jumps on planned national cancer vaccine effort
Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up
Can Pfizer (PFE) Turn a Forward P/E Discount into Real Returns?
Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks
4 Household Name Stocks With Dividends in Danger
Florida AG sues Pfizer over COVID vaccine in St. Lucie County court
Pfizer Inc. $PFE Shares Sold by Sapient Capital LLC
150,553 Pfizer Inc. $PFE Shares Acquired by Farther Finance Advisors LLC
Explosion in tick diseases spurs race for treatment and prevention | News & Features | ArcaMax Publishing
From Baric's Blueprint to SV40 and Back Again
Artemis Investment Management LLP Sells 3,850,879 Shares of Pfizer Inc. $PFE - Zolmax
Pfizer Inc. $PFE Holdings Lifted by Quintet Private Bank Europe S.A.
Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?
Pfizer (PFE) Could Be 3% Below Fair Value After Fresh TUKYSA FDA Approval
Artemis Investment Management LLP Sells 3,850,879 Shares of Pfizer Inc. $PFE - Daily Political
Pfizer Is Just One Of These 3 AI Healthcare Stocks
Pfizer (PFE) Wins TUKYSA Approval And LITFULO Data, Is It Still 3% Undervalued?
FDA Approves Pfizer's TUKYSA Regimen For Front-Line HER2+ Breast Cancer Maintenance
Pfizer (NYSE:PFE) Given New $28.00 Price Target at Cantor Fitzgerald - Daily Political
Pfizer's TUKYSA Gets FDA Nod For Front-Line HER2+ Breast Cancer Maintenance
Fake pharma racket sourced Pfizer labels from Turkiye: SIT | India News
AI Breakthrough: Room Temperature Storage for mRNA Vaccines, ETPharma
Pfizer Job Cuts Italy: Pfizer to Lay Off 330 Workers at Sicily Plant Amid Industry Cuts, ETHRWorld
Combined limbal dysmaturation and microcyst like epithelial changes with corneal nerve alterations of a novel anti nectin-4-MMAE antibody drug conjugate
Canandaigua National Trust Co of Florida Purchases New Shares in Pfizer Inc. $PFE - Zolmax
Canandaigua National Trust Co of Florida Buys New Position in Pfizer Inc. $PFE
Pfizer (PFE) Trades Below 10x Earnings. Why Does Johnson & Johnson (JNJ) Command More Than Twice the Multiple?
Pfizer (PFE) Trades Below Its Own Average Multiple, Is It Cheap for a Reason?
Pfizer Gets FDA Approval for Expanded Use of Breast-Cancer Treatment Tukysa | Morningstar
Pfizer (NYSE:PFE) Stock Price Up 1.7% After Dividend Announcement - Stock Observer
Pfizer's TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer | Morningstar
Pfizer (PFE) Posted Positive Phase 3 Vitiligo Results For LITFULO
Pfizer Inc. (NYSE:PFE) Shareholders to Collect $0.43 Quarterly Dividend - Zolmax
Pfizer Inc. (NYSE:PFE) Shareholders Set to Receive $0.43 Quarterly Dividend
Warren Buffett's Favorite Valuation Indicator Blew Past the Level He Warned Was "Playing With Fire." Here Are 3 Stocks Still Cheap Enough to Buy. - AOL
Johnson & Johnson $JNJ Stock Holdings Cut by Hall Laurie J Trustee - Markets Daily
Is Pfizer (PFE) a Good or Bad Investment at Today's Price?
5,446 Shares in Johnson & Johnson $JNJ Bought by Eleva Capital SAS - Zolmax
Johnson & Johnson $JNJ Shares Newly Purchased by Eleva Capital SAS
Pfizer Declares $0.43 Fourth-Quarter Dividend For Shareholders
PFIZER news
Trump Announces 25% Tariffs on Automobiles, Pharmaceuticals, and Semiconductors
Week Ahead: US And Canada Labour Markets Are In Focus, BoE Rate Decision
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
